Futoshi Nara Selected Research

Futoshi Nara Research Topics

2	Hypoglycemia (Reactive Hypoglycemia) 08/2013 - 10/2012
2	Arthritis (Polyarthritis) 05/2012 - 03/2009
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2012 - 05/2011
2	Multiple Sclerosis 07/2011 - 05/2011
2	Atopic Dermatitis (Atopic Eczema) 10/2010 - 12/2009
1	Hereditary Nephritis (Alport Syndrome) 01/2022
1	Proteinuria 01/2022
1	Ischemia 11/2019
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Hyperkalemia 01/2017
1	Myocardial Infarction 01/2017
1	Cardiomegaly (Heart Hypertrophy) 01/2017
1	Heart Failure 01/2017
1	Ovarian Neoplasms (Ovarian Cancer) 01/2015
1	Bradycardia 08/2014
1	Type 2 Diabetes Mellitus (MODY) 08/2013
1	Animal Disease Models 05/2012
1	Neoplasms (Cancer) 01/2012
1	Lung Neoplasms (Lung Cancer) 01/2012
1	Autoimmune Diseases (Autoimmune Disease) 07/2011
1	Shock 10/2010
1	Necrosis 10/2010
1	Inflammation (Inflammations) 01/2010
1	Asthma (Bronchial Asthma) 01/2010

2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2015 - 01/2012
2	Glucose (Dextrose)FDA LinkGeneric 08/2013 - 10/2012
2	CS 0777IBA 07/2011 - 05/2011
2	CCR4 ReceptorsIBA 10/2010 - 01/2010
2	OvalbuminIBA 10/2010 - 01/2010
1	CreatinineIBA 01/2022
1	bardoxolone methylIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	salicylhydroxamic acid (SHAM)IBA 11/2019
1	Proprotein Convertase 9IBA 01/2018
1	Mineralocorticoid Receptor AntagonistsIBA 01/2017
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2017
1	PotassiumIBA 01/2017
1	AldosteroneIBA 01/2017
1	Protons (Proton)IBA 01/2015
1	Insulin SecretagoguesIBA 08/2013
1	CS-2100IBA 05/2012
1	Diethylstilbestrol (Stilbestrol)FDA Link 01/2012
1	3-aminoisobutyric acidIBA 01/2012
1	Estradiol Congeners (Synthetic Estrogens)IBA 01/2012
1	beta-AlanineIBA 01/2012
1	Hormones (Hormone)IBA 01/2012
1	LigandsIBA 01/2012
1	Sphingosine-1-Phosphate ReceptorsIBA 07/2011
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 07/2011
1	LipopolysaccharidesIBA 10/2010
1	RS-1269IBA 10/2010
1	2- (4- (2- (diethylamino)ethoxy)phenyl)- N- (2,4- difluorobenzyl)- 5- fluoropyrimidin- 4- amineIBA 01/2010
1	3- (2- (2- phenyl- 4- (4- pyridin- 4- ylbenzyl)morpholin- 2- yl)ethyl)quinazoline- 2,4(1H,3H)- dioneIBA 12/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2009
1	Collagen Type II (Type II Collagen)IBA 03/2009

2	Oral Administration 08/2014 - 10/2010
1	Therapeutics 01/2018